Journal Home
Search for

Volume 2, Issue 4, Pages 167-170 (2009)


View previous. 2 of 8 View next.

Epidemiology and outcome of snake bite cases evaluated at a Tertiary Care Hospital in Oman

Adil Al-Lawatia, Seif S. Al-AbriaCorresponding Author Informationemail address, David G. Lalloob

Received 25 May 2009; received in revised form 11 July 2009; accepted 10 September 2009.

Summary 

Objectives

To study the epidemiology of snake bite patients evaluated at the Royal Hospital, Muscat, Sultanate of Oman, and to study their clinical course and outcome.

Methods

A retrospective study of 65 adult patients presenting at Royal Hospital following a snake bite from May 2006 to August 2008.

Results

The main symptoms were local pain at the bite site (26 patients, 40%) and swelling (17 patients, 26%). Only five patients (7.7%) had signs of bleeding. After assessment, only 47 of the 65 patients were admitted. White cell count (WCC) was raised in 15 cases (23%) on presentation to the emergency room. Prothrombin time was prolonged in 34 patients (52%) and APTT was prolonged in 25 patients (38%) on presentation. Thirty-six patients received anti-snake venom (antivenom) at a mean time of 8h after the bite and 4h after arrival in the emergency department. Patients with deranged coagulation profile needed a mean of fourteen vials of antivenom for correction of the abnormal coagulation profile. Two patients died: both had delayed presentation to the hospital.

Conclusion

Patients with envenoming following snakebite should receive antivenom as soon as possible: delayed presentation or administration may be very dangerous. The decision to give antivenom should be initiated as soon as possible after patients’ arrival at the Emergency Department and the use of the whole blood clotting test (WBCT) may facilitate the early administration of antivenom.

a Royal Hospital, Oman

b Liverpool School of Tropical Medicine, United Kingdom

Corresponding Author InformationCorresponding author at: P.O. Box 2657, CPO 111, Muscat, Oman. Tel.: +968 24599000; fax: +968 24599966.

PII: S1876-0341(09)00062-8

doi:10.1016/j.jiph.2009.09.001


View previous. 2 of 8 View next.